The U.S. attorney’s office in Buffalo has issued a subpoena to the Ista Pharmaceuticals Inc. requesting it to produce documents regarding an anti-inflammatory drug. The drug in question is Xibrom, used in treatment of inflammatory infections of the eye after cataract surgery. The company has said in a statement that it will be cooperating with the request, though it did not specify the reason for such a request.